Meyenburg Award for 2010 for the Discoverer of the Breast Cancer Gene BRCA 2

The Meyenburg Award for 2010, which is endowed with EUR 50,000, goes to the British biochemist and breast cancer specialist Alan Ashworth. He is being honoured for his discovery of a completely new type of cancer treatment. The use of so-called PARP inhibitors in breast cancer patients in whom the breast cancer genes BRCA1 and BRCA2 are modified in the tumour tissue is considered to be a breakthrough in cancer treatment. The award, which since 1981 has been given out for outstanding achievements in cancer research, is one of the most generously endowed science awards in Germany. The Meyenburg Award is conferred during a symposium in the German Cancer Research Centre.

back